News
Warwick Acoustics completes £7m funding round
The spinout company whose patented loudspeaker technology is set to revolutionise in-car audio systems has raised a further £7m in a funding round led by Mercia and including NFU Mutual and private investors.
Clinical trials success for Medherant
Warwick spinout Medherant is pleased to announce preliminary results of trials of its testosterone patch for post menopausal women.
Warwick spinout Cytoswim receives FDA clearance
Cytoswim has received clearance from the U.S. Food and Drug Administration (FDA) for its novel SpermAlign device which helps select high quality sperm for use in Assistive Reproductive Techniques.
New Warwick spin-out company SEEV
Could e-voting be the future for general elections?
Revolutionising AI for cellular pathology
Warwick spin-out Histofy to revolutionise AI for cellular pathology.
Tools to solve global challenges
Equipping entrepreneurs and start-ups with the tools needed to solve global challenges.
Synthetic biology platform
NanoSyrinx raises £6.2m to develop its synthetic biology platform for targeted intracellular engineering.
Medherant to develop world’s only testosterone patch for menopause
Warwick spin out company Medherant to develop world’s only testosterone patch for menopause.